US$ 26.06
do you have to be on glp 1 forever Take GLP-1 Medications Forever? Do You Have To Keep
Description
Compared with patients without diabetes, patients with diabetes have a 2fourfold higher risk of atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease, stroke, and peripheral artery disease [1]

But research on GLP-1 microdosing in menopausal populations is limited
The most important and most frequently used indication for DPP-4 inhibitors is their add-on use in patients who are not sufficiently controlled on metformin monotherapy ( DPP-4 inhibitors can be administered in patients with impaired kidney function due to the good safety and tolerability

Rare but more serious side effects can include pancreatitis or gallbladder disease

Wegovy | European Medicines Agency (EMA)
